Detail Information of Exogenous Modulation

General Information of Drug Transporter (DT)
DT ID DTD0002 Transporter Info
Gene Name ABCC2
Transporter Name Multidrug resistance-associated protein 2
Gene ID
1244
UniProt ID
Q92887
Exogenous factors (drugs, dietary constituents, etc.) Modulation of This DT (EGM)

Approved Drug

  Cyclosporine

            6 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Cyclosporine inhibits the transportation of Calcein AM by ABCC2 (IC50 = 10 microM) [1]

Affected Drug/Substrate

 Calcein AM Modulation Type Inhibition

Cell System

 Madin Darby canine kidney strain II (MDCKII) cells-MRP2

  DT Modulation 2

 Cyclosporine inhibits the transportation of Leukotriene C4 by ABCC2 (Ki = 4.7 microM) [2]

Affected Drug/Substrate

 Leukotriene C4 Modulation Type Inhibition

Cell System

 LLC-PK1 vesicles-MRP2

  DT Modulation 3

 Cyclosporine inhibits the transportation of Monoglucuronosyl bilirubin by ABCC2 (Ki = 21 microM) [3]

Affected Drug/Substrate

 Monoglucuronosyl bilirubin Modulation Type Inhibition

Cell System

 Human embryonic kidney 293 cells (HEK293)-MRP2

  DT Modulation 4

 Cyclosporine inhibits the transportation of Vinblastine by ABCC2 (Ki = 8.11 microM) [4]

Affected Drug/Substrate

 Vinblastine Modulation Type Inhibition

Cell System

 Madin Darby canine kidney strain II (MDCKII) cells-MRP2

  DT Modulation 5

 Cyclosporine inhibits the transportation of Calcein AM by ABCC2 [5]

Affected Drug/Substrate

 Calcein AM Modulation Type Inhibition

Cell System

 Madin Darby canine kidney strain II (MDCKII) cells-MRP2

  DT Modulation 6

 Cyclosporine inhibits the activity of ABCC2 [6] , [7]

  Vinblastine

            2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Vinblastine inhibits the transportation of Calcein AM by ABCC2 (IC50 = 21 microM) [12]

Affected Drug/Substrate

 Calcein AM Modulation Type Inhibition

Cell System

 Madin-Darby Canine Kidney (MDCK) cells-MRP2

  DT Modulation 2

 Vinblastine inhibits the activity of ABCC2 [14] , [15]

  Indomethacin

            2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Indomethacin inhibits the transportation of Methotrexate by ABCC2 (IC50 = 0.06 microM) [13]

Affected Drug/Substrate

 Methotrexate Modulation Type Inhibition

Cell System

 Human embryonic kidney 293 cells (HEK293)-MRP2

  DT Modulation 2

 Indomethacin inhibits the activity of ABCC2 [16] , [17]

  Bosentan

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Bosentan inhibits the transportation of Estradiol 17b-D-glucuronide by ABCC2 [19]

Affected Drug/Substrate

 Estradiol 17b-D-glucuronide Modulation Type Inhibition

  Probenecid

            2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Probenecid inhibits the transportation of SN-38 by ABCC2 [20]

Affected Drug/Substrate

 SN-38 Modulation Type Inhibition

  DT Modulation 2

 Probenecid inhibits the activity of ABCC2 [24] , [25]

  Cisplatin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Cisplatin induces the activity of ABCC2 [21]

Cell System

 Human hepatocellular carcinoma cell line (HepG2)-MRP2

  Ritonavir

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Ritonavir inhibits the activity of ABCC2 [22] , [23]

  Dexamethasone

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Dexamethasone induces the activity of ABCC2 [26]

  Simvastatin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Simvastatin inhibits the transportation of Calcein AM by ABCC2 (IC50 = 25 +/- 2 microM) [12]

Affected Drug/Substrate

 Calcein AM Modulation Type Inhibition

Cell System

 Madin-Darby Canine Kidney (MDCK) cells-MRP2

  Gemifloxacin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Gemifloxacin inhibits the transportation of Erythromycin by ABCC2 (IC50 = 16 microM) [27]

Affected Drug/Substrate

 Erythromycin Modulation Type Inhibition

Cell System

 Madin Darby canine kidney strain II (MDCKII) cells-MRP2

  Ketoprofen

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Ketoprofen inhibits the transportation of Methotrexate by ABCC2 (IC50 = 1.4 microM) [13]

Affected Drug/Substrate

 Methotrexate Modulation Type Inhibition

Cell System

 Human embryonic kidney 293 cells (HEK293)-MRP2

  Daunorubicin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Daunorubicin inhibits the transportation of Vinblastine by ABCC2 (Ki = 49.4 microM) [4]

Affected Drug/Substrate

 Vinblastine Modulation Type Inhibition

Cell System

 Madin Darby canine kidney strain II (MDCKII) cells-MRP2

  Etoposide

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Etoposide inhibits the transportation of Vinblastine by ABCC2 (Ki = 756 microM) [4]

Affected Drug/Substrate

 Vinblastine Modulation Type Inhibition

Cell System

 Madin Darby canine kidney strain II (MDCKII) cells-MRP2

  Reserpine

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Reserpine inhibits the transportation of Vinblastine by ABCC2 (Ki = 295 microM) [4]

Affected Drug/Substrate

 Vinblastine Modulation Type Inhibition

Cell System

 Madin Darby canine kidney strain II (MDCKII) cells-MRP2

  Vincristine

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Vincristine inhibits the transportation of Vinblastine by ABCC2 (Ki = 802 microM) [4]

Affected Drug/Substrate

 Vinblastine Modulation Type Inhibition

Cell System

 Madin Darby canine kidney strain II (MDCKII) cells-MRP2

  Canagliflozin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Canagliflozin inhibits the activity of ABCC2 (IC50 = 19.3 microM) [30]

  Delavirdine

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Delavirdine inhibits the transportation of 5-Chloromethylfluorescein diacetate by ABCC2 [31]

Affected Drug/Substrate

 5-Chloromethylfluorescein diacetate Modulation Type Inhibition

Cell System

 Madin Darby canine kidney strain II (MDCKII) cells-MRP2

  Efavirenz

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Efavirenz inhibits the transportation of 5-Chloromethylfluorescein diacetate by ABCC2 [31]

Affected Drug/Substrate

 5-Chloromethylfluorescein diacetate Modulation Type Inhibition

Cell System

 Madin Darby canine kidney strain II (MDCKII) cells-MRP2

  Emtricitabine

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Emtricitabine inhibits the transportation of 5-Chloromethylfluorescein diacetate by ABCC2 [31]

Affected Drug/Substrate

 5-Chloromethylfluorescein diacetate Modulation Type Inhibition

Cell System

 Madin Darby canine kidney strain II (MDCKII) cells-MRP2

  Glutathione

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Glutathione inhibits the transportation of Dinitrophenyl-glutathione by ABCC2 [32]

Affected Drug/Substrate

 Dinitrophenyl-glutathione Modulation Type Inhibition

Cell System

 Madin-Darby Canine Kidney (MDCK) cells-MRP2

  Cefaclor

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Cefaclor inhibits the transportation of Estradiol-17beta-glucuronide by ABCC2 [33]

Affected Drug/Substrate

 Estradiol-17beta-glucuronide Modulation Type Inhibition

Cell System

 Spodoptera frugiperda 21-MRP2

  Cefadroxil

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Cefadroxil inhibits the transportation of Estradiol-17beta-glucuronide by ABCC2 [33]

Affected Drug/Substrate

 Estradiol-17beta-glucuronide Modulation Type Inhibition

Cell System

 Spodoptera frugiperda 21-MRP2

  Cefamandole

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Cefamandole inhibits the transportation of Estradiol-17beta-glucuronide by ABCC2 [33]

Affected Drug/Substrate

 Estradiol-17beta-glucuronide Modulation Type Inhibition

Cell System

 Spodoptera frugiperda 21-MRP2

  Cefmetazole

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Cefmetazole inhibits the transportation of Estradiol-17beta-glucuronide by ABCC2 [33]

Affected Drug/Substrate

 Estradiol-17beta-glucuronide Modulation Type Inhibition

Cell System

 Spodoptera frugiperda 21-MRP2

  Cefoperazone

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Cefoperazone inhibits the transportation of Estradiol-17beta-glucuronide by ABCC2 [33]

Affected Drug/Substrate

 Estradiol-17beta-glucuronide Modulation Type Inhibition

Cell System

 Spodoptera frugiperda 21-MRP2

  Cefoxitin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Cefoxitin inhibits the transportation of Estradiol-17beta-glucuronide by ABCC2 [33]

Affected Drug/Substrate

 Estradiol-17beta-glucuronide Modulation Type Inhibition

Cell System

 Spodoptera frugiperda 21-MRP2

  Ceftriaxone

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Ceftriaxone inhibits the transportation of Estradiol-17beta-glucuronide by ABCC2 [33]

Affected Drug/Substrate

 Estradiol-17beta-glucuronide Modulation Type Inhibition

Cell System

 Spodoptera frugiperda 21-MRP2

  Cefuroxime

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Cefuroxime inhibits the transportation of Estradiol-17beta-glucuronide by ABCC2 [33]

Affected Drug/Substrate

 Estradiol-17beta-glucuronide Modulation Type Inhibition

Cell System

 Spodoptera frugiperda 21-MRP2

  Cephalexin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Cephalexin inhibits the transportation of Estradiol-17beta-glucuronide by ABCC2 [33]

Affected Drug/Substrate

 Estradiol-17beta-glucuronide Modulation Type Inhibition

Cell System

 Spodoptera frugiperda 21-MRP2

  Cephradine

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Cephradine inhibits the transportation of Estradiol-17beta-glucuronide by ABCC2 [33]

Affected Drug/Substrate

 Estradiol-17beta-glucuronide Modulation Type Inhibition

Cell System

 Spodoptera frugiperda 21-MRP2

  Acitretin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Acitretin inhibits the transportation of Estradiol 17b-D-glucuronide by ABCC2 [19]

Affected Drug/Substrate

 Estradiol 17b-D-glucuronide Modulation Type Inhibition

  Drospirenone

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Drospirenone inhibits the transportation of Estradiol 17b-D-glucuronide by ABCC2 [19]

Affected Drug/Substrate

 Estradiol 17b-D-glucuronide Modulation Type Inhibition

  Losartan

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Losartan inhibits the transportation of Estradiol 17b-D-glucuronide by ABCC2 [19]

Affected Drug/Substrate

 Estradiol 17b-D-glucuronide Modulation Type Inhibition

  Sulfasalazine

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Sulfasalazine inhibits the transportation of Estradiol 17b-D-glucuronide by ABCC2 [19]

Affected Drug/Substrate

 Estradiol 17b-D-glucuronide Modulation Type Inhibition

  Troglitazone

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Troglitazone inhibits the transportation of Estradiol 17b-D-glucuronide by ABCC2 [19]

Affected Drug/Substrate

 Estradiol 17b-D-glucuronide Modulation Type Inhibition

  Quercetin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Quercetin induces the activity of ABCC2 [35]

Cell System

 Human enterocyte-like 2 cell (Caco-2)-MRP2

  Rifampicin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Rifampicin induces the activity of ABCC2 [36] , [37] , [38] , [39]

Cell System

 Human hepatocellular carcinoma cell line (HepG2)-MRP2

  Chenodeoxycholic acid

            2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Chenodiol induces the activity of ABCC2 [40]

Cell System

 Human hepatocellular carcinoma cell line (HepG2)-MRP2

  DT Modulation 2

 Chenodeoxycholic acid induces the activity of ABCC2 [40] , [81] , [82]

  Clotrimazole

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Clotrimazole induces the activity of ABCC2 [37]

Cell System

 Human hepatocellular carcinoma cell line (HepG2)-MRP2

  Phenobarbital

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Phenobarbital induces the activity of ABCC2 [41]

Cell System

 Hepatocyte-MRP2

  Belinostat

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Belinostat inhibits the activity of ABCC2 [42]

Cell System

 Non-small cell lung cancer (NSCLC) cell lines

  Rifampin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Rifampin increases the expression of ABCC2 [48]

Regulation Mechanism

 via enhancement of Nuclear receptor subfamily 1 group I member 2 (NR1I2) Transcription Factor Info

Cell System

 Human duodenal mucosa biopsy specimens

  Cholic Acid

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Cholic Acid increases the expression of ABCC2 [49]

Regulation Mechanism

 via enhancement of Nuclear receptor subfamily 1 group I member 2 (NR1I2) Transcription Factor Info

Cell System

 C57BL/6 mice

  Hydrogen Peroxide

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Hydrogen Peroxide increases the expression of ABCC2 [50]

Regulation Mechanism

 via enhancement of Nuclear factor erythroid 2-related factor 2 (NFE2L2) Transcription Factor Info

Cell System

 Human neuroblastoma cells (SH-SY5Y)

  Fulvestrant

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Fulvestrant increases the expression of ABCC2 [51]

Regulation Mechanism

 via modulation of Estrogen receptor (ESR1) Transcription Factor Info

Cell System

 Human breast carcinoma cells (MCF-7)

  Ursodeoxycholic Acid

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Ursodeoxycholic Acid increases the expression of ABCC2 [52]

Regulation Mechanism

 via enhancement of Nuclear factor erythroid 2-related factor 2 (NFE2L2) Transcription Factor Info

Cell System

 C57/B6 mice

  Arsenic

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Arsenic increases the expression of ABCC2 [55]

Regulation Mechanism

 via enhancement of Nuclear factor erythroid 2-related factor 2 (NFE2L2) Transcription Factor Info

Cell System

 Zebrafish

  Decitabine

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Decitabine increases the expression of ABCC2 [56]

  Citalopram

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Citalopram increases the expression of ABCC2 [57]

  Atorvastatin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Atorvastatin inhibits the activity of ABCC2 [12]

  Lovastatin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Lovastatin inhibits the activity of ABCC2 [12]

  Progesterone

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Progesterone inhibits the activity of ABCC2 [58]

  Metformin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Metformin increases the expression of ABCC2 [59]

  Copper Sulfate

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Copper Sulfate increases the expression of ABCC2 [60]

  Topotecan

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Topotecan increases the expression of ABCC2 [61]

  Paclitaxel

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Paclitaxel affects the expression of ABCC2 [62]

  Bortezomib

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Bortezomib increases the expression of ABCC2 [63]

  Azathioprine

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Azathioprine increases the expression of ABCC2 [64]

  Bromfenac

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Bromfenac inhibits the activity of ABCC2 [65]

  Celecoxib

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Celecoxib inhibits the activity of ABCC2 [65]

  Diclofenac

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Diclofenac inhibits the activity of ABCC2 [65]

  Rosiglitazone

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Rosiglitazone inhibits the activity of ABCC2 [65]

  Ticlopidine

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Ticlopidine inhibits the activity of ABCC2 [65]

  Methotrexate

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Methotrexate increases the expression of ABCC2 [67]

  Epirubicin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Epirubicin increases the expression of ABCC2 [68]

  Tolvaptan

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Tolvaptan inhibits the activity of ABCC2 [69]

  Calcitriol

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Calcitriol increases the expression of ABCC2 [70]

  Chloroquine

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Chloroquine inhibits the expression of ABCC2 [71]

  Ethinyl Estradiol

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Ethinyl Estradiol inhibits the expression of ABCC2 [72]

  Macitentan

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Macitentan inhibits the expression of ABCC2 [73]

  Urethane

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Urethane inhibits the expression of ABCC2 [74]

  Methoxsalen

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Methoxsalen inhibits the expression of ABCC2 [75]

  Valproic Acid

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Valproic Acid inhibits the expression of ABCC2 [76]

  Titanium dioxide

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Titanium dioxide increases the expression of ABCC2 [77]

  Carbamazepine

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Carbamazepine increases the expression of ABCC2 [79]

  Acetaminophen

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Acetaminophen inhibits the expression of ABCC2 [80]

  Cimetidine

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Cimetidine inhibits the activity of ABCC2 [8]

  Etodolac

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Etodolac inhibits the activity of ABCC2 [13]

  Lansoprazole

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Lansoprazole inhibits the activity of ABCC2 [83]

  Estradiol

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Estradiol induces the activity of ABCC2 [84] , [85]

  Indinavir

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Indinavir inhibits the activity of ABCC2 [22]

  Sulfinpyrazone

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Sulfinpyrazone inhibits the activity of ABCC2 [86]

  Gentamicin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Gentamicin induces the activity of ABCC2 [87] , [88]

  Arsenic Trioxide

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Arsenic trioxide induces the activity of ABCC2 [89] , [90]

  Mycophenolic Acid

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Mycophenolic acid inhibits the activity of ABCC2 [91]

  Pravastatin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Pravastatin inhibits the activity of ABCC2 [92]

  Glyburide

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Glibenclamide inhibits the activity of ABCC2 [93]

  Verapamil

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Verapamil inhibits the activity of ABCC2 [94]

  Mitoxantrone

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Mitoxantrone inhibits the activity of ABCC2 [95]

  Lopinavir

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Lopinavir inhibits the activity of ABCC2 [96]

  Saquinavir

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Saquinavir inhibits the activity of ABCC2 [97] , [98]

  Benzbromarone

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Benzbromarone induces the activity of ABCC2 [99]

  Montelukast

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Montelukast inhibits the activity of ABCC2 [100]

  Estrone

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Estrone inhibits the activity of ABCC2 [101]

  Ketoconazole

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Ketoconazole inhibits the activity of ABCC2 [102]

  Levonorgestrel

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Levonorgestrel inhibits the activity of ABCC2 [58]

  Midecamycin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Midecamycin inhibits the activity of ABCC2 [103]

  Eprosartan

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Eprosartan induces the activity of ABCC2 [104]

  Vancomycin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Vancomycin inhibits the activity of ABCC2 [105]

  Atazanavir

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Atazanavir inhibits the activity of ABCC2 [106]

  Darunavir

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Darunavir inhibits the activity of ABCC2 [106]

  Tipranavir

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Tipranavir inhibits the activity of ABCC2 [106]

  Micafungin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Micafungin inhibits the activity of ABCC2 [107]

  Itraconazole

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Itraconazole inhibits the activity of ABCC2 [108]

  Troleandomycin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Troleandomycin induces the activity of ABCC2 [109]

  Triamcinolone

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Triamcinolone induces the activity of ABCC2 [26]

  Hydrocortisone

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Hydrocortisone induces the activity of ABCC2 [26]

Drug Marketed but not Approved by US FDA

  Ginkgolide A

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Ginkgolide A increases the expression of ABCC2 [53]

Regulation Mechanism

 via enhancement of Nuclear receptor subfamily 1 group I member 2 (NR1I2) Transcription Factor Info

Cell System

 Human hepatoblastoma cells (HepG2)

  Bezafibrate

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Bezafibrate increases the expression of ABCC2 [54]

Regulation Mechanism

 via enhancement of Nuclear receptor subfamily 1 group I member 2 (NR1I2) Transcription Factor Info

Cell System

 Human hepatocellular carcinoma (HepaRG)

  Norgestimate

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Norgestimate inhibits the activity of ABCC2 [58]

  Formononetin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Formononetin inhibits the expression of ABCC2 [66]

  Rotenone

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Rotenone inhibits the expression of ABCC2 [78]

Drug in Phase 3 Trial

  Curcumin

            4 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Curcumin inhibits the transportation of Ethacrynic acid glutathione by ABCC2 (IC50 = 5 microM) [1]

Affected Drug/Substrate

 Ethacrynic acid glutathione Modulation Type Inhibition

Cell System

 Spodoptera frugiperda (Sf9) cells-MRP2

  DT Modulation 2

 Curcumin inhibits the activity of ABCC2 (IC50 = 5 microM) [1]

Cell System

 Madin Darby canine kidney strain II (MDCKII) cells-MRP2

  DT Modulation 3

 Curcumin inhibits the transportation of Resveratrol-3-O-glucuronide by ABCC2 [11]

Affected Drug/Substrate

 Resveratrol-3-O-glucuronide Modulation Type Inhibition

Cell System

 Madin Darby canine kidney strain II (MDCKII) cells-MRP2

  DT Modulation 4

 Curcumin inhibits the activity of ABCC2 [1]

Cell System

 Spodoptera frugiperda (Sf9) cells-MRP2

  Resveratrol

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Resveratrol increases the expression of ABCC2 [115]

Regulation Mechanism

 via enhancement of Nuclear receptor subfamily 1 group I member 2 (NR1I2) Transcription Factor Info

Cell System

 Wistar rats

  Triclosan

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Triclosan increases the expression of ABCC2 [139]

  Sulforafan

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Sulforafan increases the expression of ABCC2 [146]

  Benzylpenicillin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Benzylpenicillin induces the activity of ABCC2 [149]

  Oltipraz

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Oltipraz increases the expression of ABCC2 [150]

Regulation Mechanism

 via enhancement of Nuclear factor erythroid 2-related factor 2 (NFE2L2) Transcription Factor Info

Affected Drug/Substrate

 Arsenic Modulation Type Inducer

Cell System

 Human hepatocytes

Drug in Phase 2 Trial

  Genistein

            2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Genistein induces the transportation of Sorafenib by ABCC2 [18]

Affected Drug/Substrate

 Sorafenib Modulation Type Inducer

Cell System

 Human hepatocellular carcinoma cell line (HepG2)-MRP2

  DT Modulation 2

 Genistein induces the activity of ABCC2 [18]

Cell System

 Human hepatocellular carcinoma cell line (HepG2)-MRP2

  Bisphenol A

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Bisphenol A increases the expression of ABCC2 [113]

Regulation Mechanism

 via enhancement of Nuclear factor erythroid 2-related factor 2 (NFE2L2) Transcription Factor Info

Cell System

 Human fetal liver samples

  Colforsin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Colforsin increases the expression of ABCC2 [124]

Drug in Phase 1 Trial

  Trichostatin A

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Trichostatin A inhibits the expression of ABCC2 [116]

  Rubitecan

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Rubitecan increases the expression of ABCC2 [118]

  HSDB-3466

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 HSDB-3466 inhibits the expression of ABCC2 [75]

  Adenosine Triphosphate

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Adenosine Triphosphate affects the activity of ABCC2 [142]

  Sodium arsenite

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Sodium arsenite increases the expression of ABCC2 [78]

  TAK-875

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 TAK-875 inhibits the activity of ABCC2 [147]

Drug in Preclinical Test

  Myricetin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Myricetin inhibits the activity of ABCC2 [119]

  Proadifen

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Proadifen inhibits the expression of ABCC2 [135]

  (+)-JQ1

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 (+)-JQ1 inhibits the expression of ABCC2 [136]

Discontinued Drug

  MK-571

            5 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 MK-571 inhibits the transportation of Ethacrynic acid glutathione by ABCC2 (IC50 = 4 microM) [8]

Affected Drug/Substrate

 Ethacrynic acid glutathione Modulation Type Inhibition

Cell System

 Spodoptera frugiperda (Sf9) cells-MRP2

  DT Modulation 2

 MK-571 inhibits the transportation of Irinotecan by ABCC2 (IC50 = 50 microM) [9]

Affected Drug/Substrate

 Irinotecan Modulation Type Inhibition

Cell System

 Human enterocyte-like 2 cell (Caco-2)-MRP2

  DT Modulation 3

 MK-571 inhibits the transportation of Leukotriene C4 by ABCC2 (Ki = 13.1 microM) [2]

Affected Drug/Substrate

 Leukotriene C4 Modulation Type Inhibition

Cell System

 LLC-PK1 vesicles-MRP2

  DT Modulation 4

 MK-571 inhibits the transportation of Vinblastine by ABCC2 (Ki = 26.4 microM) [4]

Affected Drug/Substrate

 Vinblastine Modulation Type Inhibition

Cell System

 Madin Darby canine kidney strain II (MDCKII) cells-MRP2

  DT Modulation 5

 MK-571 inhibits the transportation of Estradiol 17b-D-glucuronide by ABCC2 [10]

Affected Drug/Substrate

 Estradiol 17b-D-glucuronide Modulation Type Inhibition

Cell System

 Madin Darby canine kidney strain II (MDCKII) cells-MRP2

  Valspodar

            2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Valspodar inhibits the transportation of Leukotriene C4 by ABCC2 (Ki = 28.9 microM) [2]

Affected Drug/Substrate

 Leukotriene C4 Modulation Type Inhibition

Cell System

 LLC-PK1 vesicles-MRP2

  DT Modulation 2

 Valspodar inhibits the transportation of Vincristine by ABCC2 [2]

Affected Drug/Substrate

 Vincristine Modulation Type Inhibition

Cell System

 LLC-PK1 vesicles-MRP2

Investigative Drug

  Hyperforin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Hyperforin induces the activity of ABCC2 [40]

Cell System

 Hepatocyte-MRP2

  Lithocholic Acid

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Lithocholic Acid inhibits the expression of ABCC2 [110]

Regulation Mechanism

 via the inhibition of Bile acid receptor (NR1H4) Transcription Factor Info

Cell System

 Male mice

  Beta-naphthoflavone

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Beta-naphthoflavone increases the expression of ABCC2 [111]

Regulation Mechanism

 via enhancement of Nuclear factor erythroid 2-related factor 2 (NFE2L2) Transcription Factor Info

Cell System

 Human hepatoblastoma cells (HepG2)

  Baohuoside I

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Baohuoside I inhibits the expression of ABCC2 [144]

  Enoxolone

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Enoxolone inhibits the activity of ABCC2 [148]

Patented Pharmaceutical Agent

  K-7174

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 K-7174 increases the expression of ABCC2 [126]

  BMS 536924

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 BMS 536924 inhibits the expression of ABCC2 [133]

  GSK-J4

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 GSK-J4 increases the expression of ABCC2 [138]

Drug Withdrawn

  Sitaxsentan

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Sitaxsentan inhibits the transportation of Estradiol 17b-D-glucuronide by ABCC2 [19]

Affected Drug/Substrate

 Estradiol 17b-D-glucuronide Modulation Type Inhibition

Natural Product

  Pyrethroids

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Pyrethroids inhibits the transportation of Probenecid by ABCC2 (IC50 = 48.2 microM) [28]

Affected Drug/Substrate

 Probenecid Modulation Type Inhibition

Cell System

 Human hepatoma HuH-7 cells-MRP2

  Tetramethrin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Tetramethrin inhibits the transportation of Probenecid by ABCC2 (IC50 = 65.5 microM) [28]

Affected Drug/Substrate

 Probenecid Modulation Type Inhibition

Cell System

 Human hepatoma HuH-7 cells-MRP2

  Cigarette smoke condensate

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Cigarette smoke condensate inhibits the transportation of Rhodamine 123 by ABCC2 (IC50 = 197.4 microM) [29]

Affected Drug/Substrate

 Rhodamine 123 Modulation Type Inhibition

Cell System

 Human hepatoma HepaRG cells-MRP2

  Aged garlic extract

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Aged garlic extract induces the transportation of 2,4-Dinitrophenyl-S-glutathione by ABCC2 [34]

Affected Drug/Substrate

 2,4-Dinitrophenyl-S-glutathione Modulation Type Inducer

Cell System

 Human enterocyte-like 2 cell (Caco-2)-MRP2

  Boldine

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Boldine induces the activity of ABCC2 [43]

Cell System

 Model organism in vivo (rat)

  Green tea extract (1mg/ml)

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Green tea extract (1mg/ml) inhibits the activity of ABCC2 [44]

Cell System

 Human gastrointestinal epithelial cell line (LS-180)-MRP2

  Mix silybin A silybin B

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Mix silybin A silybin B inhibits the activity of ABCC2 [45]

Cell System

 Spodoptera frugiperda 21-MRP2

  St Johns wort extract

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 St Johns wort extract induces the activity of ABCC2 [46]

Cell System

 Model organism in vivo (rat)

  Chinese herb Jianpijiedu

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Chinese herb Jianpijiedu induces the activity of ABCC2 [47]

Cell System

 Rat breast carcinoma cell (Walker-256)-MRP2

  Ginkgolide B

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Ginkgolide B increases the expression of ABCC2 [53]

Regulation Mechanism

 via enhancement of Nuclear receptor subfamily 1 group I member 2 (NR1I2) Transcription Factor Info

Cell System

 Human hepatoblastoma cells (HepG2)

  Robinetin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Robinetin inhibits the activity of ABCC2 [119]

  6-bromoindirubin-3'-oxime

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 6-bromoindirubin-3'-oxime increases the expression of ABCC2 [122]

  Chrysin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Chrysin inhibits the activity of ABCC2 [61]

  Particulate Matter

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Particulate Matter inhibits the activity of ABCC2 [129]

  Senecionine

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Senecionine inhibits the expression of ABCC2 [131]

  Tobacco Smoke Pollution

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Tobacco Smoke Pollution increases the expression of ABCC2 [143]

Plant Extract

  Ginkgo biloba extract

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Ginkgo biloba extract increases the expression of ABCC2 [53]

Regulation Mechanism

 via enhancement of Nuclear receptor subfamily 1 group I member 2 (NR1I2) Transcription Factor Info

Cell System

 Human hepatoblastoma cells (HepG2)

  Plant Extracts

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Plant Extracts inhibits the activity of ABCC2 [44]

  Apple polyphenol extract

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Apple polyphenol extract increases the expression of ABCC2 [121]

Environmental toxicant

  2-tert-butylhydroquinone

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 2-tert-butylhydroquinone increases the expression of ABCC2 [112]

Regulation Mechanism

 via enhancement of Nuclear factor erythroid 2-related factor 2 (NFE2L2) Transcription Factor Info

Cell System

 Human hepatoblastoma cells (HepG2)

  Sodium arsenate

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Sodium arsenate increases the expression of ABCC2 [117]

  Demethoxycurcumin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Demethoxycurcumin inhibits the activity of ABCC2 [120]

Mycotoxins

  Aflatoxin B1

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Aflatoxin B1 increases the expression of ABCC2 [125]

Acute Toxic Substance

  2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine increases the expression of ABCC2 [123]

  Ochratoxin A

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Ochratoxin A inhibits the expression of ABCC2 [134]

  2-methyl-4-isothiazolin-3-one

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 2-methyl-4-isothiazolin-3-one increases the expression of ABCC2 [140]

Carcinogen

  2-acetylaminofluorene

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 2-acetylaminofluorene increases the expression of ABCC2 [111]

Regulation Mechanism

 via enhancement of Nuclear factor erythroid 2-related factor 2 (NFE2L2) Transcription Factor Info

Cell System

 Human hepatoblastoma cells (HepG2)

  Benzo(a)pyrene

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Benzo(a)pyrene inhibits the expression of ABCC2 [141]

Pesticide/Insecticide

  Chlordecone

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Chlordecone inhibits the activity of ABCC2 [128]

  Dieldrin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Dieldrin increases the expression of ABCC2 [128]

  Endosulfan

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Endosulfan inhibits the activity of ABCC2 [128]

  Heptachlor

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Heptachlor inhibits the activity of ABCC2 [128]

  Dicrotophos

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Dicrotophos increases the expression of ABCC2 [137]

Health and Environmental Toxicant

  Perfluorooctane sulfonic acid

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Perfluorooctane sulfonic acid increases the expression of ABCC2 [114]

Regulation Mechanism

 via enhancement of Peroxisome proliferator-activated receptor alpha (PPARA) Transcription Factor Info

Cell System

 Sprague Dawley rats

  Chlordan

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Chlordan inhibits the activity of ABCC2 [128]

  Butyraldehyde

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Butyraldehyde inhibits the expression of ABCC2 [130]

  tris(1,3-dichloro-2-propyl)phosphate

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 tris(1,3-dichloro-2-propyl)phosphate increases the expression of ABCC2 [132]

Herbicide

  Monomethylarsonic acid

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Monomethylarsonic acid increases the expression of ABCC2 [127]

  2,4,5-trichlorophenoxyacetic Acid

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 2,4,5-trichlorophenoxyacetic Acid increases the expression of ABCC2 [111]

Chemical Compound

  Gold

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Gold increases the expression of ABCC2 [145]
References
1 Interplay between MRP inhibition and metabolism of MRP inhibitors: the case of curcumin. Chem Res Toxicol. 2003 Dec;16(12):1642-51.
2 Effect of multidrug resistance-reversing agents on transporting activity of human canalicular multispecific organic anion transporter. Mol Pharmacol. 1999 Dec;56(6):1219-28.
3 Transport of monoglucuronosyl and bisglucuronosyl bilirubin by recombinant human and rat multidrug resistance protein 2. Hepatology. 1999 Aug;30(2):485-90.
4 Are MDCK cells transfected with the human MRP2 gene a good model of the human intestinal mucosa? Pharm Res. 2002 Jun;19(6):773-9.
5 2-Indolylmethylenebenzofuranones as first effective inhibitors of ABCC2. Eur J Med Chem. 2016 Oct 21;122:408-418.
6 Value of therapeutic drug monitoring of MMF therapy in pediatric transplantation. Pediatr Transplant. 2006 Sep;10(6):707-11.
7 Absence of drug interaction between Hwang-Ryun-Hae-Dok-Tang and phenolsulfonphthalein. Arch Pharm Res. 2010 Dec;33(12):2025-31.
8 Effects of fibrates on human organic anion-transporting polypeptide 1B1-, multidrug resistance protein 2- and P-glycoprotein-mediated transport. Xenobiotica. 2005 Jul;35(7):737-53.
9 Intestinal transport of irinotecan in Caco-2 cells and MDCK II cells overexpressing efflux transporters Pgp, cMOAT, and MRP1. Drug Metab Dispos. 2002 Jul;30(7):763-70.
10 Evaluation and prediction of potential drug-drug interactions of linagliptin using in vitro cell culture methods. Drug Metab Dispos. 2013 Jan;41(1):149-58.
11 Curcumin Affects Phase II Disposition of Resveratrol Through Inhibiting Efflux Transporters MRP2 and BCRP. Pharm Res. 2016 Mar;33(3):590-602.
12 Differential interaction of 3-hydroxy-3-methylglutaryl-coa reductase inhibitors with ABCB1, ABCC2, and OATP1B1. Drug Metab Dispos. 2005 Apr;33(4):537-46.
13 Interaction of nonsteroidal anti-inflammatory drugs with multidrug resistance protein (MRP) 2/ABCC2- and MRP4/ABCC4-mediated methotrexate transport. J Pharmacol Exp Ther. 2007 Jan;320(1):229-35.
14 Differences in the transport of the antiepileptic drugs phenytoin, levetiracetam and carbamazepine by human and mouse P-glycoprotein. Neuropharmacology. 2007 Feb;52(2):333-46.
15 Inhibitory effect of the reversal agents V-104, GF120918 and Pluronic L61 on MDR1 Pgp-, MRP1- and MRP2-mediated transport. Br J Cancer. 2000 Aug;83(3):366-74.
16 Multiple efflux pumps are involved in the transepithelial transport of colchicine: combined effect of p-glycoprotein and multidrug resistance-associated protein 2 leads to decreased intestinal absorption throughout the entire small intestine. Drug Metab Dispos. 2009 Oct;37(10):2028-36.
17 Small intestinal efflux mediated by MRP2 and BCRP shifts sulfasalazine intestinal permeability from high to low, enabling its colonic targeting. Am J Physiol Gastrointest Liver Physiol. 2009 Aug;297(2):G371-7.
18 Regulation of multidrug resistance proteins by genistein in a hepatocarcinoma cell line: impact on sorafenib cytotoxicity. PLoS One. 2015 Mar 17;10(3):e0119502.
19 A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development. Toxicol Sci. 2013 Nov;136(1):216-41.
20 The potential for an interaction between MRP2 (ABCC2) and various therapeutic agents: probenecid as a candidate inhibitor of the biliary excretion of irinotecan metabolites. Drug Metab Pharmacokinet. 2002;17(1):23-33.
21 Up-regulation of transporters of the MRP family by drugs and toxins. Toxicol Lett. 2001 Mar 31;120(1-3):51-7.
22 Interaction of eight HIV protease inhibitors with the canalicular efflux transporter ABCC2 (MRP2) in sandwich-cultured rat and human hepatocytes. Biopharm Drug Dispos. 2010 Mar;31(2-3):178-88.
23 Interactions of HIV protease inhibitors with ATP-dependent drug export proteins. Mol Pharmacol. 1999 Aug;56(2):383-9.
24 Role of the multidrug transporter proteins ABCB1 and ABCC2 in the diaplacental transport of talinolol in the term human placenta. Drug Metab Dispos. 2008 Apr;36(4):740-4.
25 Influence of efflux transporters on liver, bile and brain disposition of amitriptyline in mice. Int J Pharm. 2009 Aug 13;378(1-2):80-5.
26 Rapid, nongenomic stimulation of multidrug resistance protein 2 (Mrp2) activity by glucocorticoids in renal proximal tubule. J Pharmacol Exp Ther. 2011 Jul;338(1):362-71.
27 Differential effect of P-gp and MRP2 on cellular translocation of gemifloxacin. Int J Pharm. 2011 Nov 25;420(1):26-33.
28 Inhibition of Human Drug Transporter Activities by the Pyrethroid Pesticides Allethrin and Tetramethrin. PLoS One. 2017 Jan 18;12(1):e0169480.
29 Alteration of human hepatic drug transporter activity and expression by cigarette smoke condensate. Toxicology. 2016 Jul 1;363-364:58-71.
30 In vitro and physiologically-based pharmacokinetic based assessment of drug-drug interaction potential of canagliflozin. Br J Clin Pharmacol. 2017 May;83(5):1082-1096.
31 Inhibition of MRP1/ABCC1, MRP2/ABCC2, and MRP3/ABCC3 by nucleoside, nucleotide, and non-nucleoside reverse transcriptase inhibitors. Drug Metab Dispos. 2007 Mar;35(3):340-4.
32 Canalicular multispecific organic anion transporter/multidrug resistance protein 2 mediates low-affinity transport of reduced glutathione. Biochem J. 1999 Mar 1;338 ( Pt 2):393-401.
33 Oral availability of cefadroxil depends on ABCC3 and ABCC4. Drug Metab Dispos. 2012 Mar;40(3):515-21.
34 Aged garlic extract stimulates p-glycoprotein and multidrug resistance associated protein 2 mediated effluxes. Biol Pharm Bull. 2009 Apr;32(4):694-9.
35 Coordinate induction by antioxidants of UDP-glucuronosyltransferase UGT1A6 and the apical conjugate export pump MRP2 (multidrug resistance protein 2) in Caco-2 cells. Biochem Pharmacol. 2000 Mar 1;59(5):467-70.
36 The effect of rifampin treatment on intestinal expression of human MRP transporters. Am J Pathol. 2000 Nov;157(5):1575-80.
37 Influence of redox-active compounds and PXR-activators on human MRP1 and MRP2 gene expression. Toxicology. 2002 Feb 28;171(2-3):137-46.
38 Expression and distribution of CYP3A genes, CYP2B22, and MDR1, MRP1, MRP2, LRP efflux transporters in brain of control and rifampicin-treated pigs. Mol Cell Biochem. 2010 Apr;337(1-2):133-43.
39 Directional trans-epithelial transport of organic anions in porcine LLC-PK1 cells that co-express human OATP1B1 (OATP-C) and MRP2. Biochem Pharmacol. 2005 Feb 1;69(3):415-23.
40 Regulation of multidrug resistance-associated protein 2 (ABCC2) by the nuclear receptors pregnane X receptor, farnesoid X-activated receptor, and constitutive androstane receptor. J Biol Chem. 2002 Jan 25;277(4):2908-15.
41 Differential regulation of multidrug resistance-associated protein 2 (MRP2) and cytochromes P450 2B1/2 and 3A1/2 in phenobarbital-treated hepatocytes. Biochem Pharmacol. 2002 Jan 15;63(2):333-41.
42 Reversal of platinum drug resistance by the histone deacetylase inhibitor belinostat. Lung Cancer. 2017 Jan;103:58-65.
43 Boldine enhances bile production in rats via osmotic and farnesoid X receptor dependent mechanisms. Toxicol Appl Pharmacol. 2015 May 15;285(1):12-22.
44 Inhibitory activity of a green tea extract and some of its constituents on multidrug resistance-associated protein 2 functionality. Planta Med. 2005 Feb;71(2):135-41.
45 Hepatocellular organic anion-transporting polypeptides (OATPs) and multidrug resistance-associated protein 2 (MRP2) are inhibited by silibinin. Drug Metab Dispos. 2013 Aug;41(8):1522-8.
46 St. John's Wort (Hypericum perforatum) induces overexpression of multidrug resistance protein 2 (MRP2) in rats: a 30-day ingestion study. Food Chem Toxicol. 2004 Jun;42(6):995-1002.
47 The Chinese Herb Jianpijiedu Contributes to the Regulation of OATP1B2 and ABCC2 in a Rat Model of Orthotopic Transplantation Liver Cancer Pretreated with Food Restriction and Diarrhea. Biomed Res Int. 2015;2015:752850.
48 Transcriptional and Post-Transcriptional Regulation of Duodenal P-Glycoprotein and MRP2 in Healthy Human Subjects after Chronic Treatment with Rifampin and Carbamazepine. Mol Pharm. 2019 Sep 3;16(9):3823-3830.; 2019 Sep 3;16(9):3823-3830.
49 Hepatoprotective role of PXR activation and MRP3 in cholic acid-induced cholestasis. Br J Pharmacol. 2007 Jun;151(3):367-76.; 2007 Jun;151(3):367-76.
50 Nuclear matrix protein (NRP/B) modulates the nuclear factor (Erythroid-derived 2)-related 2 (NRF2)-dependent oxidative stress response. J Biol Chem. 2010 Aug 20;285(34):26190-8.; 2010 Aug 20;285(34):26190-8.
51 Fulvestrant up regulates UGT1A4 and MRPs through ERalpha and c-Myb pathways: a possible primary drug disposition mechanism. Springerplus. 2013 Nov 20;2:620.; 2013 Nov 20;2:620.
52 Ursodeoxycholic acid stimulates Nrf2-mediated hepatocellular transport, detoxification, and antioxidative stress systems in mice. Am J Physiol Gastrointest Liver Physiol. 2008 Oct;295(4):G735-47.; 2008 Oct;295(4):G735-47.
53 Bioactive terpenoids and flavonoids from Ginkgo biloba extract induce the expression of hepatic drug-metabolizing enzymes through pregnane X receptor, constitutive androstane receptor, and aryl hydrocarbon receptor-mediated pathways. Pharm Res. 2009 Apr;26(4):872-82.
54 Anticholestatic effects of bezafibrate in patients with primary biliary cirrhosis treated with ursodeoxycholic acid. Hepatology. 2013 May;57(5):1931-41.
55 Nrf2-dependent protection against acute sodium arsenite toxicity in zebrafish. Toxicol Appl Pharmacol. 2016 Aug 15;305:136-142.; 2016 Aug 15;305:136-142.
56 Methylation-dependent silencing of the reduced folate carrier gene in inherently methotrexate-resistant human breast cancer cells. J Biol Chem. 2001 Oct 26;276(43):39990-40000.
57 Antidepressant induced cholestasis: hepatocellular redistribution of multidrug resistant protein (MRP2). Gut. 2003 Feb;52(2):300-3.
58 Interaction of progestins with the human multidrug resistance-associated protein 2 (MRP2). Drug Metab Dispos. 2005 Nov;33(11):1576-9.
59 Species-specific toxicity of diclofenac and troglitazone in primary human and rat hepatocytes. Chem Biol Interact. 2009 Apr 15;179(1):17-24.
60 Physiological and toxicological transcriptome changes in HepG2 cells exposed to copper. Physiol Genomics. 2009 Aug 7;38(3):386-401.
61 Chrysin blocks topotecan-induced apoptosis in Caco-2 cells in spite of inhibition of ABC-transporters. Biochem Pharmacol. 2010 Aug 15;80(4):471-9.
62 Evaluation of drug transporters' significance for multidrug resistance in head and neck squamous cell carcinoma. Head Neck. 2011 Jul;33(7):959-68.
63 Proteasome inhibitors MG-132 and bortezomib induce AKR1C1, AKR1C3, AKR1B1, and AKR1B10 in human colon cancer cell lines SW-480 and HT-29. Chem Biol Interact. 2011 May 30;191(1-3):239-49.
64 A transcriptomics-based in vitro assay for predicting chemical genotoxicity in vivo. Carcinogenesis. 2012 Jul;33(7):1421-9.
65 In vitro approach to assess the potential for risk of idiosyncratic adverse reactions caused by candidate drugs. Chem Res Toxicol. 2012 Aug 20;25(8):1616-32.
66 Formononetin potentiates epirubicin-induced apoptosis via ROS production in HeLa cells in vitro. Chem Biol Interact. 2013 Oct 5;205(3):188-97.
67 Methotrexate normalizes up-regulated folate pathway genes in rheumatoid arthritis. Arthritis Rheum. 2013 Nov;65(11):2791-802.
68 Co-encapsulation of chrysophsin-1 and epirubicin in PEGylated liposomes circumvents multidrug resistance in HeLa cells. Chem Biol Interact. 2015 Dec 5;242:13-23.
69 Inhibition of Human Hepatic Bile Acid Transporters by Tolvaptan and Metabolites: Contributing Factors to Drug-Induced Liver Injury?. Toxicol Sci. 2016 Jan;149(1):237-50.
70 Vitamin D3 transactivates the zinc and manganese transporter SLC30A10 via the Vitamin D receptor. J Steroid Biochem Mol Biol. 2016 Oct;163:77-87.
71 Autophagy inhibition upregulates CD4+ tumor infiltrating lymphocyte expression via miR-155 regulation and TRAIL activation. Mol Oncol. 2016 Dec;10(10):1516-1531.
72 UDCA and CDCA alleviate 17alpha-ethinylestradiol-induced cholestasis through PKA-AMPK pathways in rats. Toxicol Appl Pharmacol. 2016 Nov 15;311:12-25.
73 From the Cover: MechanisticInsights in Cytotoxic and Cholestatic Potential of the Endothelial Receptor Antagonists Using HepaRG Cells. Toxicol Sci. 2017 Jun 1;157(2):451-464.
74 Ethyl carbamate induces cell death through its effects on multiple metabolic pathways. Chem Biol Interact. 2017 Nov 1;277:21-32.
75 ABC-transporter blockage mediated by xanthotoxin and bergapten is the major pathway for chemosensitization of multidrug-resistant cancer cells. Toxicol Appl Pharmacol. 2017 Dec 15;337:22-29.
76 Integrated 'omics analysis reveals new drug-induced mitochondrial perturbations in human hepatocytes. Toxicol Lett. 2018 Jun 1;289:1-13.
77 Genome-wide DNA methylome and transcriptome changes induced by inorganic nanoparticles in human kidney cells after chronic exposure. Cell Biol Toxicol. 2022 Jan 1.
78 Capturing time-dependent activation of genes and stress-response pathways using transcriptomics in iPSC-derived renal proximal tubule cells. Cell Biol Toxicol. 2022 Dec 31.
79 Transcriptional profiling of genes induced in the livers of patients treated with carbamazepine. Clin Pharmacol Ther. 2006 Nov;80(5):440-456.
80 Multiple microRNAs function as self-protective modules in acetaminophen-induced hepatotoxicity in humans. Arch Toxicol. 2018 Feb;92(2):845-858.
81 Clinical trial: modulation of human placental multidrug resistance proteins in cholestasis of pregnancy by ursodeoxycholic acid. Aliment Pharmacol Ther. 2007 Oct 15;26(8):1139-46.
82 Role of nuclear bile acid receptor, FXR, in adaptive ABC transporter regulation by cholic and ursodeoxycholic acid in mouse liver, kidney and intestine. J Hepatol. 2003 Oct;39(4):480-8.
83 KEGG: new perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res. 2017 Jan 4;45(D1):D353-D361. (dg:DG02867)
84 Inhibition of transport across the hepatocyte canalicular membrane by the antibiotic fusidate. Biochem Pharmacol. 2002 Jul 1;64(1):151-8.
85 Involvement of Mrp2/MRP2 in the species different excretion route of benzylpenicillin between rat and human. Xenobiotica. 2009 Feb;39(2):171-81.
86 Vinblastine and sulfinpyrazone export by the multidrug resistance protein MRP2 is associated with glutathione export. Br J Cancer. 2000 Aug;83(3):375-83.
87 Increased apical insertion of the multidrug resistance protein 2 (MRP2/ABCC2) in renal proximal tubules following gentamicin exposure. J Pharmacol Exp Ther. 2006 Sep;318(3):1194-202.
88 Short-term exposure of renal proximal tubules to gentamicin increases long-term multidrug resistance protein 2 (Abcc2) transport function and reduces nephrotoxicant sensitivity. J Pharmacol Exp Ther. 2005 Nov;315(2):912-20.
89 MRP2 and acquired tolerance to inorganic arsenic in the kidney of killifish (Fundulus heteroclitus). Toxicol Sci. 2007 May;97(1):103-10.
90 Effects of MRP2-GSH cotransport system on hepatic arsenic metabolism in rats. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. 2006 May;24(5):278-80.
91 C-440T/T-331C polymorphisms in the UGT1A9 gene affect the pharmacokinetics of mycophenolic acid in kidney transplantation. Pharmacogenomics. 2007 Sep;8(9):1127-41.
92 Role of transporters in the tissue-selective distribution and elimination of drugs: transporters in the liver, small intestine, brain and kidney. J Control Release. 2002 Jan 17;78(1-3):43-54.
93 Estimation of transporters involved in the hepatobiliary transport of TA-0201CA using sandwich-cultured rat hepatocytes from normal and multidrug resistance-associated protein 2-deficient rats. Drug Metab Dispos. 2010 Sep;38(9):1505-13.
94 Molecular mechanisms of biliary excretion of cefditoren and the effects of cefditoren on the expression levels of hepatic transporters. Drug Metab Pharmacokinet. 2010;25(4):320-7.
95 Presence or absence of a gallate moiety on catechins affects their cellular transport. J Pharm Pharmacol. 2008 Sep;60(9):1189-95.
96 Peptide prodrugs: improved oral absorption of lopinavir, a HIV protease inhibitor. Int J Pharm. 2008 Jul 9;359(1-2):7-14.
97 Multidrug resistance protein 2 (MRP2) transports HIV protease inhibitors, and transport can be enhanced by other drugs. AIDS. 2002 Nov 22;16(17):2295-301.
98 Evidence for two interacting ligand binding sites in human multidrug resistance protein 2 (ATP binding cassette C2). J Biol Chem. 2003 Jun 27;278(26):23538-44.
99 Transport of diclofenac by breast cancer resistance protein (ABCG2) and stimulation of multidrug resistance protein 2 (ABCC2)-mediated drug transport by diclofenac and benzbromarone. Drug Metab Dispos. 2009 Jan;37(1):129-36.
100 Montelukast is a potent and durable inhibitor of multidrug resistance protein 2-mediated efflux of taxol and saquinavir. Biol Pharm Bull. 2009 Dec;32(12):2002-9.
101 Modulation of human multidrug resistance protein (MRP) 1 (ABCC1) and MRP2 (ABCC2) transport activities by endogenous and exogenous glutathione-conjugated catechol metabolites. Drug Metab Dispos. 2008 Mar;36(3):552-60.
102 CYP1A1 induction and CYP3A4 inhibition by the fungicide imazalil in the human intestinal Caco-2 cells-comparison with other conazole pesticides. Toxicol Lett. 2009 Feb 10;184(3):159-68.
103 Potential cholestatic activity of various therapeutic agents assessed by bile canalicular membrane vesicles isolated from rats and humans. Drug Metab Pharmacokinet. 2003;18(1):16-22.
104 Interaction of angiotensin receptor type 1 blockers with ATP-binding cassette transporters. Biopharm Drug Dispos. 2010 Mar;31(2-3):150-61.
105 JBP485 attenuates vancomycin-induced nephrotoxicity by regulating the expressions of organic anion transporter (Oat) 1, Oat3, organic cation transporter 2 (Oct2), multidrug resistance-associated protein 2 (Mrp2) and P-glycoprotein (P-gp) in rats. Toxicol Lett. 2018 Oct 1;295:195-204.
106 MRP2 Inhibition by HIV Protease Inhibitors in Rat and Human Hepatocytes: A Quantitative Confocal Microscopy Study. Drug Metab Dispos. 2018 May;46(5):697-703.
107 Inhibitory Potential of Antifungal Drugs on ATP-Binding Cassette Transporters P-Glycoprotein, MRP1 to MRP5, BCRP, and BSEP. Antimicrob Agents Chemother. 2016 May 23;60(6):3372-9.
108 Evaluation of Ketoconazole and Its Alternative Clinical CYP3A4/5 Inhibitors as Inhibitors of Drug Transporters: The In Vitro Effects of Ketoconazole, Ritonavir, Clarithromycin, and Itraconazole on 13 Clinically-Relevant Drug Transporters. Drug Metab Dispos. 2016 Mar;44(3):453-9.
109 Interactions of pharmaceuticals and other xenobiotics on key detoxification mechanisms and cytoskeleton in Poeciliopsis lucida hepatocellular carcinoma, PLHC-1 cell line. Toxicol In Vitro. 2013 Feb;27(1):111-20.
110 Preventive effect of Juniperus procera extract on liver injury induced by lithocholic acid. Cell Mol Biol (Noisy-le-grand). 2018 Oct 30;64(13):63-68.; 2018 Oct 30;64(13):63-68.
111 Role of Nrf2 in the regulation of the Mrp2 (ABCC2) gene. Biochem J. 2006 May 1;395(3):599-609.
112 Nrf2-dependent and -independent induction of ABC transporters ABCC1, ABCC2, and ABCG2 in HepG2 cells under oxidative stress. J Exp Ther Oncol. 2007;6(4):335-48.
113 Correlation between Conjugated Bisphenol A Concentrations and Efflux Transporter Expression in Human Fetal Livers. Drug Metab Dispos. 2016 Jul;44(7):1061-5.; 2016 Jul;44(7):1061-5.
114 PPAR-alpha, a lipid-sensing transcription factor, regulates blood-brain barrier efflux transporter expression. J Cereb Blood Flow Metab. 2017 Apr;37(4):1199-1212.; 2017 Apr;37(4):1199-1212.
115 Resveratrol modifies biliary secretion of cholephilic compounds in sham-operated and cholestatic rats. World J Gastroenterol. 2017 Nov 21;23(43):7678-7692.
116 Characterization of the 5'-flanking region of the human multidrug resistance protein 2 (MRP2) gene and its regulation in comparison withthe multidrug resistance protein 3 (MRP3) gene. Eur J Biochem. 2000 Mar;267(5):1347-58.
117 Global alteration of gene expression in human keratinocytes by inorganic arsenic. Carcinogenesis. 2003 Apr;24(4):747-56.
118 Analysis of ATP-binding cassette transporter expression in drug-selected cell lines by a microarray dedicated to multidrug resistance. Mol Pharmacol. 2004 Dec;66(6):1397-405.
119 Quantitative structure activity relationship studies on the flavonoid mediated inhibition of multidrug resistance proteins 1 and 2. Biochem Pharmacol. 2005 Feb 15;69(4):699-708.
120 Inhibition of multidrug resistance proteins MRP1 and MRP2 by a series of alpha,beta-unsaturated carbonyl compounds. Biochem Pharmacol. 2005 Jun 15;69(12):1879-90.
121 Apple polyphenols modulate expression of selected genes related to toxicological defence and stress response in human colon adenoma cells. Int J Cancer. 2008 Jun 15;122(12):2647-55.
122 Activation of beta-catenin signalling by GSK-3 inhibition increases p-glycoprotein expression in brain endothelial cells. J Neurochem. 2008 Aug;106(4):1855-65.
123 ABCG2/BCRP decreases the transfer of a food-born chemical carcinogen, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in perfused term human placenta. Toxicol Appl Pharmacol. 2008 Oct 15;232(2):210-7.
124 Induction of cells differentiation and ABC transporters expression by a myco-estrogen, zearalenone, in human choriocarcinoma cell line (BeWo). Toxicology. 2009 Sep 19;263(2-3):100-7.
125 The effects of aflatoxin B1 on transporters and steroid metabolizing enzymes in JEG-3 cells. Toxicol Lett. 2013 Apr 26;218(3):200-6.
126 A low-molecular-weight compound K7174 represses hepcidin: possible therapeutic strategy against anemia of chronic disease. PLoS One. 2013 Sep 27;8(9):e75568.
127 Methylarsonous acid causes oxidative DNA damage in cells independent of the ability to biomethylate inorganic arsenic. Arch Toxicol. 2014 Feb;88(2):249-61.
128 Regulation of hepatic drug transporter activity and expression by organochlorine pesticides. J Biochem Mol Toxicol. 2014 Mar;28(3):119-28.
129 Regulation of human hepatic drug transporter activity and expression by diesel exhaust particle extract. PLoS One. 2015 Mar 24;10(3):e0121232.
130 Integrated analysis of microRNA and mRNA expression profiles highlights aldehyde-induced inflammatory responses in cells relevant for lung toxicity. Toxicology. 2015 Aug 6;334:111-21.
131 Disturbance of gene expression in primary human hepatocytes by hepatotoxic pyrrolizidine alkaloids: A whole genome transcriptome analysis. Toxicol In Vitro. 2015 Oct;29(7):1669-82.
132 Defensive and adverse energy-related molecular responses precede tris (1, 3-dichloro-2-propyl) phosphate cytotoxicity. J Appl Toxicol. 2016 May;36(5):649-58.
133 Enhancement effect of resveratrol on the intestinal absorption of bestatin by regulating PEPT1, MDR1 and MRP2 in vivo and in vitro. Int J Pharm. 2015 Nov 10;495(1):588-598.
134 Modulation of the xenobiotic transformation system and inflammatory response by ochratoxin A exposure using a co-culture system of Caco-2 and HepG2 cells. Food Chem Toxicol. 2015 Dec;86:245-52.
135 Proadifen sensitizes resistant ovarian adenocarcinoma cells to cisplatin. Toxicol Lett. 2016 Jan 22;243:56-66.
136 CCAT1 is an enhancer-templated RNA that predicts BET sensitivity in colorectal cancer. J Clin Invest. 2016 Feb;126(2):639-52.
137 Molecular mechanisms of discrotophos-induced toxicity in HepG2 cells: The role of CSA in oxidative stress. Food Chem Toxicol. 2017 May;103:253-260.
138 Inhibition of histone H3K27 demethylases selectively modulates inflammatory phenotypes of natural killer cells. J Biol Chem. 2018 Feb 16;293(7):2422-2437.
139 Triclosan treatment decreased the antitumor effect of sorafenib on hepatocellular carcinoma cells. Onco Targets Ther. 2018 May 18;11:2945-2954.
140 Methylisothiazolinone induces apoptotic cell death via matrix metalloproteinase activation in human bronchial epithelial cells. Toxicol In Vitro. 2020 Feb;62:104661.
141 Identification of a transcriptomic signature of food-relevant genotoxins in human HepaRG hepatocarcinoma cells. Food Chem Toxicol. 2020 Jun;140:111297.
142 Human multidrug resistance protein 4 (MRP4) is a cellular efflux transporter for paracetamol glutathione and cysteine conjugates. Arch Toxicol. 2020 Sep;94(9):3027-3032.
143 Integration of transcriptome analysis with pathophysiological endpoints to evaluate cigarette smoke toxicity in an in vitro human airway tissue model. Arch Toxicol. 2021 May;95(5):1739-1761.
144 Baohuoside I inhibits FXR signaling pathway to interfere with bile acid homeostasis via targeting ER alpha degradation. Cell Biol Toxicol. 2022 Jul 8.
145 Biocorona modulates the inflammatory response induced by gold nanoparticles in human epidermal keratinocytes. Toxicol Lett. 2022 Oct 1;369:34-42.
146 Molecular mechanisms of hepatotoxic cholestasis by clavulanic acid: Role of NRF2 and FXR pathways. Food Chem Toxicol. 2021 Dec;158:112664.
147 Fasiglifam (TAK-875): Mechanistic Investigation and Retrospective Identification of Hazards for Drug Induced Liver Injury. Toxicol Sci. 2018 Jun 1;163(2):374-384.
148 Inhibitory effects of terpenoids on multidrug resistance-associated protein 2- and breast cancer resistance protein-mediated transport. Drug Metab Dispos. 2008 Jul;36(7):1206-11.
149 Interactions of the human multidrug resistance proteins MRP1 and MRP2 with organic anions. Mol Pharmacol. 2000 Apr;57(4):760-8.
150 Characterization of arsenic hepatobiliary transport using sandwich-cultured human hepatocytes. Toxicol Sci. 2015 Jun;145(2):307-20.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.